The SELLAR trial will test the efficacy of oral eflornithine on recurring anaplastic astrocytoma as the trial now opens for enrollment reports the Brain Tumour Charity in the UK. Sponsored by Orbus Therapeutics, the clinical trial now commences across North America,...
Landon Solberg, a 12-year-old boy from West Fargo, ND, doesn’t have much time left, given the stage of his rare malignant brain tumor known as anaplastic astrocytoma. He was diagnosed at 10. No chemo or effective treatment for this form of cancer exists. After...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
